Spruzit InsektFri koncentrat

Primær information

  • Handelsnavn:
  • Spruzit InsektFri koncentrat Flydende middel
  • Lægemiddelform:
  • Flydende middel
  • Sammensætning:
  • 160 g/l piperonylbutoxid; 36 g/l pyrethrin I og II
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Spruzit InsektFri koncentrat Flydende middel
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 364-1
  • Sidste ændring:
  • 08-02-2018

Indlægsseddel

Koncentrat

Meget effektivt

Hurtigtvirkende

Giver opblandet 20 liter væske

20 ml

Må kun bruges til privat anvendelse samt indendørs til bekæmpelse af visse

skadegørere i knudekål, salat, bladselleri, krydderurter, persille, spinat og

rucola, kirsebær, blommer, æbler, pærer og kartofler samt prydplanter

Mellus

Bladlus

Uldlus

Trips

Anvendelse:

InsektFri

effektivt

bekæm-

pelse af alle insekter (lus, nellike-

trips,

væksthusmellus

m.m.)

frugt,

grøntsager

prydplanter.

Sprøjt

opblandede

væske

direkte på skadevolderne og på de

plantedele, hvorpå de sidder. Sprøjt

også

undersiden

bladene,

men undgå afdrypning. Undgå at

behandle i direkte sol eller regnvejr.

Indhold og opblanding:

Indeholder 20 ml koncentrat, som

opblandet med vand giver 20 liter

væske klar til brug. 20 dråber (1 ml)

InsektFri

koncentrat

opblandes

liter

vand.

Aktivstoffet

pyrethrin er udtrukket af krysante-

mumblomsten.

Aktivstoffet

nedbrudt efter ca. 3 dage og der

ikke

forventes

langtidsvirk-

ning. Naturligt forekommende og

udsatte

nyttedyr

også

blive

bekæmpet.

Praktiske oplysninger:

Rester

skal

afleveres

kommunale

affaldsordning

farligt

affald.

Tomme

beholdere

bortskaffes

dagrenova-

tionen. Den tomme beholder bør

skylles inden bortskaffelse.

Deklaration:

36 g/l pyrethrin (I+II)

160 g/l piperonylbutoxid

Insektmiddel nr. 364-1

Omfattet af Miljøministeriets bek. om

bekæmpelsesmidler.

Advarsel:

For at nedsætte risikoen for mennesker

og

miljø

skal

brugsanvisningen

følges

nøje.

Meget giftig for organismer, der lever i

vand.

forårsage

uønskede

lang-

tidsvirkninger

vandmiljøet.

Vær

mærksom

på,

Arbejdstilsynets

regler for anvendelsen. Læs mere i den

evt. lovpligtige leverandørbrugsanvisning

samt i Arbejdstilsynets informationsma-

teriale

bekæmpelsesmidler.

Over-

trædelse af nedenstående særligt frem-

hævede forskrifter kan medføre straf:

Må kun bruges til privat anvendelse og

indendørs

til

bekæmpelse

af

visse

skadegørere i knudekål, salat, bladselleri,

krydderurter,

persille,

spinat

og

rucola,

kirsebær,

blommer,

æbler,

pærer

og

kartofler samt prydplanter.

kun

udbringes

ved

anvendelse

af

håndsprøjte.

ikke

anvendes

mod

andre

skadevoldere

og

ikke

i

højere

doseringer

end

de

i

brugsanvisningen

nævnte.

i

knudekål

ikke

anvendes

senere end 7 dage før høst. Må i kirsebær,

blommer, æbler, pærer, salat, bladselleri,

krydderurter,

persille,

spinat,

rucola

og

kartofler

ikke

anvendes

senere

end

3

dage før høst.

Må ikke anvendes nærmere end 20 m fra

vandmiljøet (søer, vandløb m.v.).

Opbevares

utilgængeligt

for

børn.

ikke

tømmes

i

kloakudløb.

Undgå

for-

urening

af

vandmiljøet

med

produktet

eller med beholdere, der har indeholdt

produktet

(rens

ikke

sprøjteudstyr

nær

overfladevand/undgå

forurening

via

dræn fra gårdspladser og veje).

Opbevares

utilgængeligt

for

børn.

ikke opbevares sammen med fødevarer,

drikkevarer og foderstoffer.

InsektFri

InsektFri

InsektFri

Spruzit®

Miljøfarlig

FARLIG

FOR

BIER

707883 009384

Godkendelsesindehaver: Neudorff GmbH KG · Tyskland

Distributør: ECOstyle A/S · Rugårdsvej 877 · Hindevad

5471 Søndersø · Tlf. +45 6383 2030

27-3-2018

FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices

FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices

The authorization classifies integrated continuous glucose monitoring devices in class II and subjects them to certain criteria called special controls

FDA - U.S. Food and Drug Administration

13-3-2018

Oregon Food Bank Issues Alert on Foreign Material in Chia Seeds

Oregon Food Bank Issues Alert on Foreign Material in Chia Seeds

Oregon Food Bank of Portland, Oregon has initiated a Class II recall of 22,201 pounds of chia seeds, which were donated to the food bank. The product may be contaminated with rodent droppings. While no known illnesses have been associated with this product, use or consumption may present a health hazard to consumers.

FDA - U.S. Food and Drug Administration

21-12-2017

FDA approves drug to treat dangerously low blood pressure

FDA approves drug to treat dangerously low blood pressure

The FDA today approved the new drug Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.

FDA - U.S. Food and Drug Administration

24-11-2017

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) is voluntarily recalling two lots of Riomet® (Metformin Hydrochloride Oral Solution), 500 mg/5mL, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet® (Metformin Hydrochloride Oral Solution) has been fo...

FDA - U.S. Food and Drug Administration

21-11-2017

Public Notification: S.W.A.G II Platinum 33K contains hidden drug ingredient

Public Notification: S.W.A.G II Platinum 33K contains hidden drug ingredient

The Food and Drug Administration (FDA) is advising consumers not to purchase or use S.W.A.G II Platinum 33K, a product promoted for sexual enhancement. This product was identified by FDA during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

17-10-2017

Permobil powered wheelchairs - Corpus II seating system

Permobil powered wheelchairs - Corpus II seating system

Recall for product correction - potential for injury due to breakage of the seating system

Therapeutic Goods Administration - Australia

10-4-2018

Kineret (Swedish Orphan Biovitrum AB (publ))

Kineret (Swedish Orphan Biovitrum AB (publ))

Kineret (Active substance: Anakinra) - Centralised - 2-Monthly update - Commission Decision (2018)2188 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/363/II/56

Europe -DG Health and Food Safety

3-4-2018

AQUAFLORA PHASE II (Candida Albicans) Liquid [King Bio Inc]

AQUAFLORA PHASE II (Candida Albicans) Liquid [King Bio Inc]

Updated Date: Apr 3, 2018 EST

US - DailyMed

27-3-2018

Translarna (PTC Therapeutics International Limited)

Translarna (PTC Therapeutics International Limited)

Translarna (Active substance: ataluren) - Centralised - 2-Monthly update - Commission Decision (2018)1967 of Tue, 27 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2720/II/39

Europe -DG Health and Food Safety

27-3-2018

Atripla (Bristol-Myers Squibb and Gilead Sciences Limited)

Atripla (Bristol-Myers Squibb and Gilead Sciences Limited)

Atripla (Active substance: efavirenz / emtricitabine / tenofovir disoproxil fumarate) - Centralised - 2-Monthly update - Commission Decision (2018)1953 of Tue, 27 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/797/II/127/G

Europe -DG Health and Food Safety

27-3-2018

Isentress (Merck Sharp and Dohme Limited)

Isentress (Merck Sharp and Dohme Limited)

Isentress (Active substance: raltegravir) - Centralised - 2-Monthly update - Commission Decision (2018)1962 of Tue, 27 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/860/II/64

Europe -DG Health and Food Safety

26-3-2018

ERAVAC (Laboratorios Hipra, S.A.)

ERAVAC (Laboratorios Hipra, S.A.)

ERAVAC (Active substance: rabbit haemorrhagic disease vaccine (inactivated)) - Centralised - 2-Monthly update - Commission Decision (2018)1924 of Mon, 26 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/4239/II/3/G

Europe -DG Health and Food Safety

22-3-2018

Invirase (Roche Registration Limited)

Invirase (Roche Registration Limited)

Invirase (Active substance: Saquinavir) - Centralised - 2-Monthly update - Commission Decision (2018)1844 of Thu, 22 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/113/II/122

Europe -DG Health and Food Safety

14-3-2018

CONQUEST II (Chloroxylenol) Solution [Kay Chemical Co]

CONQUEST II (Chloroxylenol) Solution [Kay Chemical Co]

Updated Date: Mar 14, 2018 EST

US - DailyMed

8-3-2018

BIOLOGICAL COMPLEX II (Anthracinum,) Liquid [Deseret Biologicals, Inc.]

BIOLOGICAL COMPLEX II (Anthracinum,) Liquid [Deseret Biologicals, Inc.]

Updated Date: Mar 8, 2018 EST

US - DailyMed

5-3-2018

Ameluz (Biofrontera Bioscience GmbH)

Ameluz (Biofrontera Bioscience GmbH)

Ameluz (Active substance: 5-Aminolaevulinic acid) - Centralised - 2-Monthly update - Commission Decision (2018)1424 of Mon, 05 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2204/II/27G

Europe -DG Health and Food Safety

5-3-2018

EU/3/16/1789 (La Jolla Pharmaceutical II BV)

EU/3/16/1789 (La Jolla Pharmaceutical II BV)

EU/3/16/1789 (Active substance: Synthetic human hepcidin) - Transfer of orphan designation - Commission Decision (2018)1427 of Mon, 05 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/144/16/T/02

Europe -DG Health and Food Safety

5-3-2018

EU/3/15/1555 (La Jolla Pharmaceutical II BV)

EU/3/15/1555 (La Jolla Pharmaceutical II BV)

EU/3/15/1555 (Active substance: Synthetic hepcidin) - Transfer of orphan designation - Commission Decision (2018)1426 of Mon, 05 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/092/15/T/02

Europe -DG Health and Food Safety

26-2-2018

Trulicity (Eli Lilly Nederland B.V.)

Trulicity (Eli Lilly Nederland B.V.)

Trulicity (Active substance: dulaglutide) - Centralised - 2-Monthly update - Commission Decision (2018)1236 of Mon, 26 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2825/II/22

Europe -DG Health and Food Safety

22-2-2018

Vectormune ND (CEVA-Phylaxia Co. Ltd.)

Vectormune ND (CEVA-Phylaxia Co. Ltd.)

Vectormune ND (Active substance: Cell-associated live recombinant turkey herpes virus (rHVT/ND) expressing the fusion protein of Newcastle diseases virus D-26 lentogenic strain) - Centralised - 2-Monthly update - Commission Decision (2018)1182 of Thu, 22 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/3829/II/7

Europe -DG Health and Food Safety

19-2-2018

Emselex (Merus Labs Luxco II S.A R.L.)

Emselex (Merus Labs Luxco II S.A R.L.)

Emselex (Active substance: darifenacin hydrobromide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1071 of Mon, 19 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/554/T/65

Europe -DG Health and Food Safety

8-2-2018

GREAT II LOTIONIZED ANTISEPTIC (Chloroxylenol) Soap [MEYER LABORATORY]

GREAT II LOTIONIZED ANTISEPTIC (Chloroxylenol) Soap [MEYER LABORATORY]

Updated Date: Feb 8, 2018 EST

US - DailyMed

8-2-2018

GIAPREZA (Angiotensin Ii) Injection [La Jolla Pharmaceutical Company]

GIAPREZA (Angiotensin Ii) Injection [La Jolla Pharmaceutical Company]

Updated Date: Feb 8, 2018 EST

US - DailyMed

7-2-2018

Truvada (Gilead Sciences International Limited)

Truvada (Gilead Sciences International Limited)

Truvada (Active substance: emtricitabine / tenofovir disoproxil fumarate) - Centralised - 2-Monthly update - Commission Decision (2018)731 of Wed, 07 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/594/II/135

Europe -DG Health and Food Safety

2-2-2018

OXYGEN Gas [Acute Care Gases II, LLC]

OXYGEN Gas [Acute Care Gases II, LLC]

Updated Date: Feb 2, 2018 EST

US - DailyMed

26-1-2018

IBRANCE (Pfizer Limited)

IBRANCE (Pfizer Limited)

IBRANCE (Active substance: palbociclib) - Centralised - 2-Monthly update - Commission Decision (2018)548 of Fri, 26 Jan 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3853/II/7

Europe -DG Health and Food Safety

22-1-2018

XALKORI (Pfizer Limited)

XALKORI (Pfizer Limited)

XALKORI (Active substance: crizotinib) - Centralised - 2-Monthly update - Commission Decision (2018)415 of Mon, 22 Jan 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2489/II/50

Europe -DG Health and Food Safety

15-12-2017

EU/3/17/1950 (MeiraGTx UK II Limited)

EU/3/17/1950 (MeiraGTx UK II Limited)

EU/3/17/1950 (Active substance: Adenovirus associated viral vector serotype 8 containing the human AIPL1 gene) - Orphan designation - Commission Decision (2017)8782 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/162/17

Europe -DG Health and Food Safety

13-12-2017

Zyclara (Meda AB)

Zyclara (Meda AB)

Zyclara (Active substance: imiquimod) - Centralised - 2-Monthly update - Commission Decision (2017)8702 of Wed, 13 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2387/II/13

Europe -DG Health and Food Safety

8-12-2017

CATEGORY II (Immune System Booster) Liquid [Vitality Works, Inc]

CATEGORY II (Immune System Booster) Liquid [Vitality Works, Inc]

Updated Date: Dec 8, 2017 EST

US - DailyMed

4-12-2017

DERMACLEAR PURITY CLEANSER LEVEL II (Benzoyl Peroxide) Gel [Allure Labs, Inc.]

DERMACLEAR PURITY CLEANSER LEVEL II (Benzoyl Peroxide) Gel [Allure Labs, Inc.]

Updated Date: Dec 4, 2017 EST

US - DailyMed

17-11-2017

Savene (Clinigen Healthcare Limited)

Savene (Clinigen Healthcare Limited)

Savene (Active substance: Dexrazoxane) - Centralised - 2-Monthly update - Commission Decision (2017)7742 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/682/II/34

Europe -DG Health and Food Safety

17-11-2017

Lemtrada (Genzyme Therapeutics Ltd)

Lemtrada (Genzyme Therapeutics Ltd)

Lemtrada (Active substance: Alemtuzumab) - Centralised - 2-Monthly update - Commission Decision (2017) 7765 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/3718/II/17

Europe -DG Health and Food Safety

17-11-2017

Zytiga (Janssen-Cilag International NV)

Zytiga (Janssen-Cilag International NV)

Zytiga (Active substance: abiraterone) - Centralised - 2-Monthly update - Commission Decision (2017) 7769 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2321/II/47

Europe -DG Health and Food Safety

14-11-2017

Pegasys (Roche Registration Limited)

Pegasys (Roche Registration Limited)

Pegasys (Active substance: peginterferon alfa-2a) - Centralised - 2-Monthly update - Commission Decision (2017)7635 of Tue, 14 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/395/II/91

Europe -DG Health and Food Safety

3-11-2017

MOTION SICKNESS II (Meclizine Hcl) Tablet [CVS Pharmacy]

MOTION SICKNESS II (Meclizine Hcl) Tablet [CVS Pharmacy]

Updated Date: Nov 3, 2017 EST

US - DailyMed

23-10-2017

Revestive (Shire Pharmaceuticals Ireland Limited)

Revestive (Shire Pharmaceuticals Ireland Limited)

Revestive (Active substance: teduglutide) - Centralised - 2-Monthly update - Commission Decision (2017) 7165 of Mon, 23 Oct 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2345/II/37

Europe -DG Health and Food Safety

23-10-2017

Firazyr (Shire Orphan Therapies GmbH)

Firazyr (Shire Orphan Therapies GmbH)

Firazyr (Active substance: icatibant) - Centralised - 2-Monthly update - Commission Decision (2017) 7158 of Mon, 23 Oct 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/899/II/34/G

Europe -DG Health and Food Safety

23-10-2017

Pradaxa (Boehringer Ingelheim International GmbH)

Pradaxa (Boehringer Ingelheim International GmbH)

Pradaxa (Active substance: dabigatran etexilate mesilate) - Centralised - 2-Monthly update - Commission Decision (2017)7166 of Mon, 23 Oct 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/829/II/103

Europe -DG Health and Food Safety

28-9-2017

SLEEP II NIGHTTIME SLEEP AID (Diphenhydramine Hcl) Tablet [Walgreen Company]

SLEEP II NIGHTTIME SLEEP AID (Diphenhydramine Hcl) Tablet [Walgreen Company]

Updated Date: Sep 28, 2017 EST

US - DailyMed

20-9-2017

Gazyvaro (Roche Registration Limited)

Gazyvaro (Roche Registration Limited)

Gazyvaro (Active substance: obinutuzumab) - Centralised - Variation - Commission Decision (2017)6426 of Wed, 20 Sep 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/002799/II/0016

Europe -DG Health and Food Safety

20-9-2017

RoActemra (Roche Registration Limited)

RoActemra (Roche Registration Limited)

RoActemra (Active substance: tocilizumab) - Centralised - 2-Monthly update - Commission Decision (2017)6425 of Wed, 20 Sep 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/000955/II/0066

Europe -DG Health and Food Safety

18-9-2017

Sovaldi (Gilead Sciences International Limited)

Sovaldi (Gilead Sciences International Limited)

Sovaldi (Active substance: sofosbuvir) - Centralised - 2-Monthly update - Commission Decision (2017)6293 of Mon, 18 Sep 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/002798/II/0036

Europe -DG Health and Food Safety

29-8-2017

KEYTRUDA (Merck Sharp and Dohme Limited)

KEYTRUDA (Merck Sharp and Dohme Limited)

KEYTRUDA (Active substance: pembrolizumab) - Centralised - 2-Monthly update - Commission Decision (2017)5943 of Tue, 29 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/003820/II/23/G

Europe -DG Health and Food Safety

28-8-2017

Dacogen (Janssen-Cilag International NV)

Dacogen (Janssen-Cilag International NV)

Dacogen (Active substance: Decitabine) - Centralised - 2-Monthly update - Commission Decision (2017)5941 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2221/II/31

Europe -DG Health and Food Safety

28-8-2017

EDURANT (Janssen-Cilag International NV)

EDURANT (Janssen-Cilag International NV)

EDURANT (Active substance: rilpivirine) - Centralised - 2-Monthly update - Commission Decision (2017)5942 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2264/II/24

Europe -DG Health and Food Safety

28-8-2017

BYDUREON (AstraZeneca AB)

BYDUREON (AstraZeneca AB)

BYDUREON (Active substance: exenatide) - Centralised - 2-Monthly update - Commission Decision (2017)5937 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2020/II/41

Europe -DG Health and Food Safety

28-8-2017

Fluenz Tetra (AstraZeneca AB)

Fluenz Tetra (AstraZeneca AB)

Fluenz Tetra (Active substance: influenza vaccine (live attenuated, nasal)) - Centralised - Variation - Commission Decision (2017)5938 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2617/II/72

Europe -DG Health and Food Safety